Inventor · disambiguated record
Huaixiang Hao
Also filed as: HAO HUAIXIANG
4 granted patents·11 pending applications·10 citations·filing 2010–2022
65Inventor score
Top patents by PatentIndex Score
15 records- 0178US10195208B2Combination therapyNOVARTIS AG·Filed 2015·Granted Feb 5, 2019·5 cites·26 claims
- 0276US9296826B2Antibodies and methods for WNT pathway-related diseasesCONG FENG·Filed 2012·Granted Mar 29, 2016·5 cites·10 claims
- 0362US12053470B2Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitorNOVARTIS AG·Filed 2022·Granted Aug 6, 2024·0 cites·7 claims
- 0454US2019203301A1Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation statusNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0551US2015125857A1CANCER PATIENT SELECTION FOR ADMINISTRATION OF Wnt SIGNALING INHIBITORS USING RNF43 MUTATION STATUSNOVARTIS AG·Filed 2013·Application pending·0 cites
- 0648US2017306409A1Cancer patient selection for administration of wnt signaling inhibitors using rnf43 mutation statusNOVARTIS AG·Filed 2016·Application pending·0 cites
- 0747US2024238284A1Compounds and compositions for the treatment of mpnstNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0847US2023172928A1Pharmaceutical combination comprising tno155 and nazartinibNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0944US12343344B2Pharmaceutical combination comprising TNO155 and ribociclibNOVARTIS AG·Filed 2020·Granted Jul 1, 2025·0 cites·6 claims
- 1043US2022160706A1Pharmaceutical combination comprising tno155 and a pd-1 inhibitorNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1143US2020101077A1Combination therapyNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1242US2019343836A1Pharmaceutical combination comprising an alk inhibitor and a shp2 inhibitorNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1339US2018066067A1Antibodies and methods for wnt pathway-related diseasesCONG FENG·Filed 2016·Application pending·0 cites
- 1435US2017224692A1Combination TherapyHAO HUAIXIANG·Filed 2015·Application pending·0 cites
- 1528US2011165560A1Methods and compositions for screening for individuals at risk for succinate dehydrogenase-related disease conditionsRUTTER JARED·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Huaixiang Hao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →